Published in Brain Res on June 19, 2006
Two forms of long-term depression in a polysynaptic pathway in the leech CNS: one NMDA receptor-dependent and the other cannabinoid-dependent. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2009) 0.85
Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians. Eur J Pharmacol (2006) 0.81
Synthesis and biological evaluation of new 1,3-thiazolidine-4-one derivatives of nitro-l-arginine methyl ester. Chem Cent J (2016) 0.78
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. Eur J Pharmacol (2007) 0.78
The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of Rat. Iran J Pharm Res (2015) 0.75
Trichotillomania and trichobezoar: a clinical practice insight with report of illustrative case. J Am Osteopath Assoc (2006) 1.70
The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care. Am J Psychiatry (2009) 1.64
Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract (2010) 1.53
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22
Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend (2009) 1.15
β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids (2010) 1.11
The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations. Pharmacol Ther (2010) 1.07
Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) (2008) 1.04
Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol Biochem Behav (2009) 1.03
Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives. Curr Med Res Opin (2013) 1.02
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice. J Pharmacol Exp Ther (2003) 1.01
An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav (2007) 0.97
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract (2012) 0.97
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. Eur J Pharmacol (2008) 0.97
beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behav Pharmacol (2010) 0.97
Nicotine behavioral pharmacology: clues from planarians. Drug Alcohol Depend (2011) 0.95
Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis. J Pharmacol Toxicol Methods (2010) 0.95
Family functioning and peer affiliation in children of fathers with antisocial personality disorder and substance dependence: associations with problem behaviors. Am J Psychiatry (2002) 0.94
First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians. Behav Pharmacol (2010) 0.94
Geospatial technology and the "exposome": new perspectives on addiction. Am J Public Health (2013) 0.94
Transversus abdominis block: clinical uses, side effects, and future perspectives. Pain Pract (2013) 0.94
Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. Br J Pharmacol (2009) 0.92
Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations. Pain Pract (2011) 0.91
Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) (2011) 0.88
Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians. Physiol Behav (2013) 0.88
Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol (2005) 0.88
Sigma sites mediate DTG-evoked hypothermia in rats. Pharmacol Biochem Behav (2002) 0.88
Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting. J Clin Anesth (2012) 0.86
On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data. Drug Alcohol Depend (2010) 0.85
Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Methods (2005) 0.85
Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J (2012) 0.85
Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies. Obesity (Silver Spring) (2011) 0.82
Role of pharmacogenetics in variable response to drugs: focus on opioids. Expert Opin Drug Metab Toxicol (2008) 0.82
Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain. J Pain Res (2012) 0.82
A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J Pharmacol Toxicol Methods (2004) 0.82
Withdrawal-like behavior in planarians is dependent on drug exposure duration. Neurosci Lett (2008) 0.81
Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res (2004) 0.81
Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide production. Pharmacol Biochem Behav (2009) 0.80
Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5). Eur J Pharmacol (2007) 0.80
Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina. Int J Dev Biol (2012) 0.80
Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians. Synapse (2008) 0.80
Opioid antagonists for pain. Expert Opin Investig Drugs (2013) 0.79
Tapentadol extended release for chronic pain patients. Adv Ther (2013) 0.79
Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opin Pharmacother (2011) 0.79
Behavioral characterization of serotonergic activation in the flatworm Planaria. Behav Pharmacol (2008) 0.79
Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians. Neuropeptides (2008) 0.79
Preliminary observations of a novel topical oil with analgesic properties for treatment of acute and chronic pain syndromes. Pain Pract (2010) 0.78
Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology (2005) 0.78
Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity. Expert Opin Drug Saf (2014) 0.78
In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism. Neurosci Lett (2012) 0.78
Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature. J Pain Res (2012) 0.77
Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition. Pharm Res (2004) 0.77
Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. J Clin Pharm Ther (2002) 0.77
Looking beyond the administered drug: metabolites of opioid analgesics. J Fam Pract (2008) 0.77
Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. Eur J Pharmacol (2006) 0.76
Pain and obesity in the older adult. Curr Pharm Des (2014) 0.76
Olanzapine overdose: a pediatric case report. J Child Adolesc Psychopharmacol (2002) 0.76
Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay. Amino Acids (2011) 0.76
Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. Eur J Pharmacol (2004) 0.76
Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations. Curr Pharm Des (2012) 0.76
Liquid chromatography-mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma. J Pharmacol Toxicol Methods (2005) 0.76
Acetaminophen and metabolite: lack of effect on nitric oxide synthase (constitutive or inducible). Headache (2002) 0.76
Combining opioid and adrenergic mechanisms for chronic pain. Postgrad Med (2014) 0.76
An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult. J Opioid Manag (2012) 0.75
'Null method' determination of drug biophase concentration. Pharm Res (2011) 0.75
Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition. Drug Alcohol Depend (2012) 0.75
5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians. Neurosci Lett (2010) 0.75
Endothelin antagonists in CION injury model. Pain (2006) 0.75
Evaluation of a novel topical essential oxygen oil for the treatment of pain in acute tendinopathy and sprains. Muscles Ligaments Tendons J (2011) 0.75
LiCl attenuates M(1)AChR-mediated intrathecal pilocarpine-induced reciprocal hindlimb scratching in mice. Pharmacology (2002) 0.75
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain. Adv Ther (2015) 0.75
Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings. J Am Osteopath Assoc (2013) 0.75
Why I like being an academic psychiatrist. Acad Psychiatry (2013) 0.75
Toward the design of ribonuclease (RNase) inhibitors: ion effects on the thermodynamics of binding of 2'-CMP to RNase A. J Pharmacol Exp Ther (2002) 0.75
Intranasal ketorolac as part of a multimodal approach to postoperative pain. Pain Pract (2014) 0.75
Considerations on the use of oxymorphone in geriatric patients. Expert Opin Drug Saf (2009) 0.75
Assessment of ADHD documentation from candidates requesting Americans With Disabilities Act (ADA) accommodations for the National Board of Osteopathic Medical Examiners COMLEX exam. J Atten Disord (2010) 0.75
Is morphine medicine's biggest misnomer? Ann Pharmacother (2012) 0.75
Response: Lack of osteopathic component in Anxiety supplement. J Am Osteopath Assoc (1997) 0.75
Long-term efficacy, safety and tolerability of Remoxy for the management of chronic pain. Expert Rev Neurother (2015) 0.75